Literature DB >> 29066100

The Selvester QRS score as a predictor of cardiac events in nonischemic dilated cardiomyopathy.

Hiroaki Hiraiwa1, Takahiro Okumura2, Akinori Sawamura1, Yuki Sugiura1, Toru Kondo1, Naoki Watanabe1, Soichiro Aoki1, Takeo Ichii1, Katsuhide Kitagawa1, Naoaki Kano1, Kenji Fukaya1, Kenji Furusawa1, Ryota Morimoto3, Kyosuke Takeshita4, Yasuko K Bando1, Toyoaki Murohara1.   

Abstract

BACKGROUND: Myocardial fibrosis is associated with poor prognosis in nonischemic dilated cardiomyopathy (NIDCM) patients. The Selvester QRS score on 12-lead electrocardiogram is associated with both the amount of myocardial scar and poor prognosis in myocardial infarction patients. However, its use in NIDCM patients is limited. We investigated the prognostic value of the QRS score and its association with collagen volume fraction (CVF) in NIDCM patients.
METHODS: We enrolled 91 consecutive NIDCM patients (66 men, 53±13 years) without permanent pacemakers or cardiac resynchronization therapy devices. The Selvester QRS score was calculated by two expert cardiologists at NIDCM diagnosis. All patients were followed up over 4.5±3.2 years. Cardiac events were defined as a composite of cardiac death, hospitalization for worsening heart failure, and lethal arrhythmia. We also evaluated CVF using endomyocardial biopsy samples.
RESULTS: At baseline, the left ventricular ejection fraction was 32±9%, plasma brain natriuretic peptide level was 80 [43-237] pg/mL, and mean Selvester QRS score was 4.1 points. Twenty cardiac events were observed (cardiac death, n=1; hospitalization for worsening heart failure, n=16; lethal arrhythmia, n=3). Cox proportional hazard regression analysis revealed that the Selvester QRS score was an independent determinant of cardiac events (hazard ratio, 1.32; 95% confidence interval, 1.05-1.67; p=0.02). The best cut-off value was determined as 3 points, with 85% sensitivity and 47% specificity (area under the curve, 0.688, p=0.011). In Kaplan-Meier survival analysis, the QRS score ≥3 group had more cardiac events than the QRS score <3 group (log-rank, p=0.007). Further, there was a significant positive correlation of Selvester QRS score with CVF (r=0.46, p<0.001).
CONCLUSIONS: The Selvester QRS score can predict future cardiac events in NIDCM, reflecting myocardial fibrosis assessed by CVF.
Copyright © 2017 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Electrocardiography; Myocardial fibrosis; Nonischemic dilated cardiomyopathy; Prognosis

Mesh:

Year:  2017        PMID: 29066100     DOI: 10.1016/j.jjcc.2017.09.002

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  4 in total

1.  Prognostic value of leucine/phenylalanine ratio as an amino acid profile of heart failure.

Authors:  Hiroaki Hiraiwa; Takahiro Okumura; Toru Kondo; Toshiaki Kato; Shingo Kazama; Yuki Kimura; Toshikazu Ishihara; Etsuo Iwata; Masafumi Shimojo; Sayano Kondo; Soichiro Aoki; Yasunori Kanzaki; Daisuke Tanimura; Hiroaki Sano; Yoshifumi Awaji; Sumio Yamada; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2021-01-22       Impact factor: 2.037

2.  Relationship between Selvester ECG Score and Cardiovascular Outcomes in Patients with Non-ST Elevation Myocardial Infarction.

Authors:  Osman Can Yontar; Guney Erdogan; Mustafa Yenercag; Sefa Gul; Ugur Arslan; Ali Karagoz
Journal:  Acta Cardiol Sin       Date:  2021-11       Impact factor: 2.672

3.  Alteration of circadian machinery in monocytes underlies chronic kidney disease-associated cardiac inflammation and fibrosis.

Authors:  Yuya Yoshida; Naoya Matsunaga; Shigehiro Ohdo; Takaharu Nakao; Kengo Hamamura; Hideaki Kondo; Tomomi Ide; Hiroyuki Tsutsui; Akito Tsuruta; Masayuki Kurogi; Michio Nakaya; Hitoshi Kurose; Satoru Koyanagi
Journal:  Nat Commun       Date:  2021-05-13       Impact factor: 14.919

4.  Selvester score predicts implantable cardioverter defibrillator shocks in patients with non-ischemic cardiomyopathy.

Authors:  Fazıl Arısoy; Ozlem Ozcan Celebi; İlke Erbay; Omaç Tufekcioglu; Sinan Aydoğdu; Ahmet Temizhan
Journal:  J Arrhythm       Date:  2021-06-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.